Sicor Inc.
The Irvine specialty pharmaceuticals company posted third-quarter net income of $8.4 million, or 8 cents a share, up from $3 million, or 3 cents a share, for the prior-year period. Revenue rose 29% to $71.7 million.
The Irvine specialty pharmaceuticals company posted third-quarter net income of $8.4 million, or 8 cents a share, up from $3 million, or 3 cents a share, for the prior-year period. Revenue rose 29% to $71.7 million.
